Enhanced antigen-specific T cell responses by activating type I IFN responses via the nuclear factor kB (NF-kB) and IFN-stimulated response element (ISRE) pathways; reduced HPV+ tumor growth. This evidence concerns the gene IFNA1 and neoplasm.